In human metastatic breast model, VCAN derived from bone marrow myeloid progenitor cells induces MET of tumor cells in the premetastatic niche via inhibition of the TGFβ/SMAD2/3 pathway [46] (Table 1). The gene discussed is TGFB1; the disease is neoplasm.